USP at CPHI Frankfurt

USP at CPHI Frankfurt Banner

USP is pleased to participate in CPHI Frankfurt, November 1–3, 2022.

Chat with the USP Team at Booth #110A30

Visit us at booth #110A30 where a team of USP experts will be on hand to answer your questions about:

  • Quality solutions, including new USP documentary standards and reference standards, and Pharmaceutical Analytical Impurities (PAI) 
  • USP’s Verification Programs for APIs, Excipients, Dietary Ingredients and Dietary Supplements
  • Advanced manufacturing solutions
  • Sustainable pharmaceutical manufacturing 
  • Novel excipients
  • Collaborating with USP to help drive the science that shapes our public standards

Interested in scheduling a meeting at CPHI Frankfurt? Email us.


Don’t miss these engaging talks led by USP and Pharmatech Associates experts

Broader Adoption of Continuous Manufacturing – Tackling the Difficult Problems
On-site Conference
November 2, 16.05-16.30 PM | Europa Room, Hall 4.0

Significant scientific and technological advancements have been made in the past two decades that have enabled continuous manufacturing (CM) of pharmaceuticals.

These include discovery of new routes for chemical synthesis, development of process monitoring and modeling techniques, and modern equipment to handle and transform materials sequentially in a continuous manufacturing line. Despite these advances, there are only a handful of products that have been approved using CM. Many manufacturers are looking to adopt such advanced manufacturing technologies but face barriers in the form of expert knowledge, economic uncertainty, and regulatory risk.

To address these barriers, it is essential to provide a platform where industry, academia, and regulators can convene to discuss, comment on, and collaborate on the best, most relevant research, develop consensus best practices, and solve collective problems.

Gabriela Grasa Mannino, PCM Programs Director, Advanced Manufacturing Technologies, USP
Lawrence De Belder, Pharmaceutical Continuous Manufacturing (PCM) Practice Lead, Pharmatech Associates, a USP company

Learn more


Strategies to Achieve Sustainable Pharmaceutical Manufacturing in LMICs

Product Innovation & Sustainability Theatre
November 2, 15.35-16.00 PM | Hall 3.1

  • Reflecting on pharmaceutical supply chain vulnerabilities in low-and middle-income countries (LMICs) exposed by the Covid-19 pandemic and efforts to expand local and regional production to include vaccines and active pharmaceutical ingredients.
  • Highlighting the new paradigm to develop sustainable pharmaceutical manufacturing, leveraging technology transfer, developing a skilled workforce, and installation of GMP-compliant facilities.
  • Leveraging lessons learned through USP’s decades of experience supporting manufacturers in LMICs.
  • Key principles to achieving sustainable pharmaceutical manufacturing in LMICs.

Speaker: Perrer Tosso, Senior Manager, Pharmaceutical Products Supply Services, USP

Learn more